Environmental Risk Assessment and its growing importance in the German Pharma Strategy

Episode 34,   Apr 14, 12:36 PM

Headliner
Share
Subscribe
Join Angela-Vogt Eisele, Associate Director Scientific Affairs at PharmaLex, a Cencora company for this podcast, where she shares her expertise in Environmental Risk Assessment and its growing importance in the German Pharma Strategy
Share
Subscribe
Next
Challenges and best practices for managing local pharmacovigilance activities
Top episodes
The New Opportunity in Pharmaceutical Outsourcing: Portfolio Maintenance
by PharmaLex Talks
Managing the medical device pre-submission process with the FDA
by PharmaLex Talks
Post Brexit landscape for the pharmaceutical industry
by PharmaLex Talks